ZDHHC6 and colorectal carcinoma: It is worth mentioning that patients with elevated levels of ZDHHC6 or PPARγ experienced significantly shorter overall survival compared to patients with low levels of ZDHHC6 or PPARγ in the TCGA CRC and ICGC CRC databases (Fig. 9G, H).